U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07187583) titled 'Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps' on Sept. 11.
Brief Summary: The purpose of this study is to investigate the feasibility of extending the dosing intervals of biological therapies while maintaining optimal treatment effects in chronic rhinosinusitis with nasal polyps (CRSwNP).
Study Start Date: June 05
Study Type: INTERVENTIONAL
Condition:
Chronic Rhinosinusitis With Nasal Polyps
Intervention:
DRUG: increased dosing interval of biological therapy
Increasing dosing interval of biological therapy for CRSwNP from every 4 weeks to every 6 weeks and if continued satisfactory response then to every...